F036 Oral Signs of Systemic Disease
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Prompt detection of oral signs and symptoms that may suggest underlying systemic disease can be invaluable to the general dermatologist in reaching a diagnosis. In this forum, the oral signs of a broad array of systemic illnesses including infectious, nutritional, hematologic, paraneoplastic and autoimmune & vesiculobullous diseases will be discussed. The session will provide an overview of associated key signs and salient features to look for on oral mucosal examination and relevant questions in the patient history. The format will be case based to include diagnosis, work-up and treatment pearls in addition to reviewing basic principles of oral procedures.
LEARNING OBJECTIVES
Recognize the salient oral findings associated with infectious, nutritional, autoimmune, and vesiculobullous diseases.
Apply diagnostic and therapeutic pearls for the management of patients with oral mucosal disease.
Describe the basic surgical principles of oral procedures and assess their potential benefits to your own practice.
SCHEDULE
6:00 PM
Introduction to oral diseases, anatomy, and medications
Walter Liszewski, MD, FAAD
6:15 PM
Bullous diseases of the oral mucosa
Kyle T Amber, MD, FAAD
6:40 PM
Connective tissue, autoimmune, and inflammatory skin disorders of the mouth
Angad Arinder Chadha, MD, FAAD
7:05 PM
Oral signs of severe drug reactions, cutaneous oncology, and inpatient cutaneous diseases
Cuong Nguyen, MD, FAAD
7:30 PM
Oral signs of allergic contact dermatitis and chronic urticaria
Walter Liszewski, MD, FAAD
7:45 PM
Q and A
SPEAKERS
Kyle T Amber, MD, FAAD
Angad Arinder Chadha, MD, FAAD
Walter Liszewski, MD, FAAD
Cuong Nguyen, MD, FAAD
SPEAKER DISCLOSURES
Kyle T Amber, MD, FAAD
Akari Therapeutics – Consultant(Honoraria); arGEN-X – Consultant(Honoraria); AstraZeneca – Investigator(Grants/Research Funding); kabafusion – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Angad Arinder Chadha, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria);
Walter Liszewski, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Leo Foundation – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria);
Cuong Nguyen, MD, FAAD
No financial relationships exist with ineligible companies.